Frontera Health Secures $32M Seed Investment to Transform Pediatric Care with AI-Driven Digital Phenotyping

Frontera Health is proud to announce a groundbreaking funding milestone of $32,000,000 that marks a significant leap forward in our mission to transform pediatric healthcare. As the first ever demonstration of AI-driven digital phenotyping for conditions such as autism, our innovative deeptech platform leverages advanced AI and machine learning techniques to build a robust, video-based data model designed to facilitate early intervention and support developmental disorders. This infusion of capital will propel our ongoing development and enable us to scale our revolutionary technology across communities. By working closely with parents, caregivers, and clinical partners, we are not just developing cutting-edge diagnostics—we are actively bridging the gap between underserved populations and quality healthcare. Our commitment to improving health equity is underscored by our services that extend beyond traditional tech deployment. We actively deploy our technologies in rural and economically challenged regions of New Mexico and Colorado, ensuring that even the most vulnerable populations have access to the care they need. This funding round, led by premier investors including Lightspeed, Lux Capital, Menlo Ventures, and Bison Ventures, is a testament to the confidence the investment community has in our vision and our ability to drive rapid, impactful growth. As we continue to refine our personalized treatment plans and expand our network of clinical collaborations, we remain steadfast in our resolve to create lasting difference in pediatric healthcare. For career inquiries and to join our mission driven team, please reach out to recruiting@frontera.health. This mark of success not only celebrates our technological innovations but also reaffirms our commitment to equitable access to care for all.